IBDEI1RL ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,28186,1,4,0)
;;=4^T43.206A
;;^UTILITY(U,$J,358.3,28186,2)
;;=^5050543
;;^UTILITY(U,$J,358.3,28187,0)
;;=T43.206S^^113^1379^7
;;^UTILITY(U,$J,358.3,28187,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28187,1,3,0)
;;=3^Underdosing of Antidepressants,Sequela
;;^UTILITY(U,$J,358.3,28187,1,4,0)
;;=4^T43.206S
;;^UTILITY(U,$J,358.3,28187,2)
;;=^5050545
;;^UTILITY(U,$J,358.3,28188,0)
;;=T43.206D^^113^1379^8
;;^UTILITY(U,$J,358.3,28188,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28188,1,3,0)
;;=3^Underdosing of Antidepressants,Subs Encntr
;;^UTILITY(U,$J,358.3,28188,1,4,0)
;;=4^T43.206D
;;^UTILITY(U,$J,358.3,28188,2)
;;=^5050544
;;^UTILITY(U,$J,358.3,28189,0)
;;=T43.506A^^113^1379^12
;;^UTILITY(U,$J,358.3,28189,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28189,1,3,0)
;;=3^Underdosing of Antipsychotics & Neuroleptics,Init Encntr
;;^UTILITY(U,$J,358.3,28189,1,4,0)
;;=4^T43.506A
;;^UTILITY(U,$J,358.3,28189,2)
;;=^5050651
;;^UTILITY(U,$J,358.3,28190,0)
;;=T43.506S^^113^1379^13
;;^UTILITY(U,$J,358.3,28190,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28190,1,3,0)
;;=3^Underdosing of Antipsychotics & Neuroleptics,Sequela
;;^UTILITY(U,$J,358.3,28190,1,4,0)
;;=4^T43.506S
;;^UTILITY(U,$J,358.3,28190,2)
;;=^5050653
;;^UTILITY(U,$J,358.3,28191,0)
;;=T43.506D^^113^1379^14
;;^UTILITY(U,$J,358.3,28191,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28191,1,3,0)
;;=3^Underdosing of Antipsychotics & Neuroleptics,Subs Encntr
;;^UTILITY(U,$J,358.3,28191,1,4,0)
;;=4^T43.506D
;;^UTILITY(U,$J,358.3,28191,2)
;;=^5050652
;;^UTILITY(U,$J,358.3,28192,0)
;;=99605^^114^1380^1^^^^1
;;^UTILITY(U,$J,358.3,28192,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,28192,1,2,0)
;;=2^MTMS BY PHARM,INIT 15 MIN
;;^UTILITY(U,$J,358.3,28192,1,3,0)
;;=3^99605
;;^UTILITY(U,$J,358.3,28193,0)
;;=99607^^114^1380^2^^^^1
;;^UTILITY(U,$J,358.3,28193,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,28193,1,2,0)
;;=2^MTMS BY PHARM, EA ADDL 15 MIN
;;^UTILITY(U,$J,358.3,28193,1,3,0)
;;=3^99607
;;^UTILITY(U,$J,358.3,28194,0)
;;=99606^^114^1381^1^^^^1
;;^UTILITY(U,$J,358.3,28194,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,28194,1,2,0)
;;=2^MTMS BY PHARM,INIT 15 MIN
;;^UTILITY(U,$J,358.3,28194,1,3,0)
;;=3^99606
;;^UTILITY(U,$J,358.3,28195,0)
;;=99607^^114^1381^2^^^^1
;;^UTILITY(U,$J,358.3,28195,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,28195,1,2,0)
;;=2^MTMS BY PHARM, EA ADDL 15 MIN
;;^UTILITY(U,$J,358.3,28195,1,3,0)
;;=3^99607
;;^UTILITY(U,$J,358.3,28196,0)
;;=98960^^114^1382^1^^^^1
;;^UTILITY(U,$J,358.3,28196,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,28196,1,2,0)
;;=2^INDIVIDUAL PATIENT, EA 30 MIN
;;^UTILITY(U,$J,358.3,28196,1,3,0)
;;=3^98960
;;^UTILITY(U,$J,358.3,28197,0)
;;=98961^^114^1382^2^^^^1
;;^UTILITY(U,$J,358.3,28197,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,28197,1,2,0)
;;=2^2-4 PATIENTS, EA 30 MIN
;;^UTILITY(U,$J,358.3,28197,1,3,0)
;;=3^98961
;;^UTILITY(U,$J,358.3,28198,0)
;;=98962^^114^1382^3^^^^1
;;^UTILITY(U,$J,358.3,28198,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,28198,1,2,0)
;;=2^5-8 PATIENTS, EA 30 MIN
;;^UTILITY(U,$J,358.3,28198,1,3,0)
;;=3^98962
;;^UTILITY(U,$J,358.3,28199,0)
;;=T74.11XA^^115^1383^7
;;^UTILITY(U,$J,358.3,28199,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28199,1,3,0)
;;=3^Adult Physical Abuse,Confirmed,Init Enctr
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1RL 3745 printed Sep 23, 2025@19:50:27 Page 2
IBDEI1RL ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,28186,1,4,0)
+2 ;;=4^T43.206A
+3 ;;^UTILITY(U,$J,358.3,28186,2)
+4 ;;=^5050543
+5 ;;^UTILITY(U,$J,358.3,28187,0)
+6 ;;=T43.206S^^113^1379^7
+7 ;;^UTILITY(U,$J,358.3,28187,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,28187,1,3,0)
+10 ;;=3^Underdosing of Antidepressants,Sequela
+11 ;;^UTILITY(U,$J,358.3,28187,1,4,0)
+12 ;;=4^T43.206S
+13 ;;^UTILITY(U,$J,358.3,28187,2)
+14 ;;=^5050545
+15 ;;^UTILITY(U,$J,358.3,28188,0)
+16 ;;=T43.206D^^113^1379^8
+17 ;;^UTILITY(U,$J,358.3,28188,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,28188,1,3,0)
+20 ;;=3^Underdosing of Antidepressants,Subs Encntr
+21 ;;^UTILITY(U,$J,358.3,28188,1,4,0)
+22 ;;=4^T43.206D
+23 ;;^UTILITY(U,$J,358.3,28188,2)
+24 ;;=^5050544
+25 ;;^UTILITY(U,$J,358.3,28189,0)
+26 ;;=T43.506A^^113^1379^12
+27 ;;^UTILITY(U,$J,358.3,28189,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,28189,1,3,0)
+30 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Init Encntr
+31 ;;^UTILITY(U,$J,358.3,28189,1,4,0)
+32 ;;=4^T43.506A
+33 ;;^UTILITY(U,$J,358.3,28189,2)
+34 ;;=^5050651
+35 ;;^UTILITY(U,$J,358.3,28190,0)
+36 ;;=T43.506S^^113^1379^13
+37 ;;^UTILITY(U,$J,358.3,28190,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,28190,1,3,0)
+40 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Sequela
+41 ;;^UTILITY(U,$J,358.3,28190,1,4,0)
+42 ;;=4^T43.506S
+43 ;;^UTILITY(U,$J,358.3,28190,2)
+44 ;;=^5050653
+45 ;;^UTILITY(U,$J,358.3,28191,0)
+46 ;;=T43.506D^^113^1379^14
+47 ;;^UTILITY(U,$J,358.3,28191,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,28191,1,3,0)
+50 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Subs Encntr
+51 ;;^UTILITY(U,$J,358.3,28191,1,4,0)
+52 ;;=4^T43.506D
+53 ;;^UTILITY(U,$J,358.3,28191,2)
+54 ;;=^5050652
+55 ;;^UTILITY(U,$J,358.3,28192,0)
+56 ;;=99605^^114^1380^1^^^^1
+57 ;;^UTILITY(U,$J,358.3,28192,1,0)
+58 ;;=^358.31IA^3^2
+59 ;;^UTILITY(U,$J,358.3,28192,1,2,0)
+60 ;;=2^MTMS BY PHARM,INIT 15 MIN
+61 ;;^UTILITY(U,$J,358.3,28192,1,3,0)
+62 ;;=3^99605
+63 ;;^UTILITY(U,$J,358.3,28193,0)
+64 ;;=99607^^114^1380^2^^^^1
+65 ;;^UTILITY(U,$J,358.3,28193,1,0)
+66 ;;=^358.31IA^3^2
+67 ;;^UTILITY(U,$J,358.3,28193,1,2,0)
+68 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
+69 ;;^UTILITY(U,$J,358.3,28193,1,3,0)
+70 ;;=3^99607
+71 ;;^UTILITY(U,$J,358.3,28194,0)
+72 ;;=99606^^114^1381^1^^^^1
+73 ;;^UTILITY(U,$J,358.3,28194,1,0)
+74 ;;=^358.31IA^3^2
+75 ;;^UTILITY(U,$J,358.3,28194,1,2,0)
+76 ;;=2^MTMS BY PHARM,INIT 15 MIN
+77 ;;^UTILITY(U,$J,358.3,28194,1,3,0)
+78 ;;=3^99606
+79 ;;^UTILITY(U,$J,358.3,28195,0)
+80 ;;=99607^^114^1381^2^^^^1
+81 ;;^UTILITY(U,$J,358.3,28195,1,0)
+82 ;;=^358.31IA^3^2
+83 ;;^UTILITY(U,$J,358.3,28195,1,2,0)
+84 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
+85 ;;^UTILITY(U,$J,358.3,28195,1,3,0)
+86 ;;=3^99607
+87 ;;^UTILITY(U,$J,358.3,28196,0)
+88 ;;=98960^^114^1382^1^^^^1
+89 ;;^UTILITY(U,$J,358.3,28196,1,0)
+90 ;;=^358.31IA^3^2
+91 ;;^UTILITY(U,$J,358.3,28196,1,2,0)
+92 ;;=2^INDIVIDUAL PATIENT, EA 30 MIN
+93 ;;^UTILITY(U,$J,358.3,28196,1,3,0)
+94 ;;=3^98960
+95 ;;^UTILITY(U,$J,358.3,28197,0)
+96 ;;=98961^^114^1382^2^^^^1
+97 ;;^UTILITY(U,$J,358.3,28197,1,0)
+98 ;;=^358.31IA^3^2
+99 ;;^UTILITY(U,$J,358.3,28197,1,2,0)
+100 ;;=2^2-4 PATIENTS, EA 30 MIN
+101 ;;^UTILITY(U,$J,358.3,28197,1,3,0)
+102 ;;=3^98961
+103 ;;^UTILITY(U,$J,358.3,28198,0)
+104 ;;=98962^^114^1382^3^^^^1
+105 ;;^UTILITY(U,$J,358.3,28198,1,0)
+106 ;;=^358.31IA^3^2
+107 ;;^UTILITY(U,$J,358.3,28198,1,2,0)
+108 ;;=2^5-8 PATIENTS, EA 30 MIN
+109 ;;^UTILITY(U,$J,358.3,28198,1,3,0)
+110 ;;=3^98962
+111 ;;^UTILITY(U,$J,358.3,28199,0)
+112 ;;=T74.11XA^^115^1383^7
+113 ;;^UTILITY(U,$J,358.3,28199,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,28199,1,3,0)
+116 ;;=3^Adult Physical Abuse,Confirmed,Init Enctr
